Cell phone and technology use by octogenarians in New Zealand was relatively low, particularly for Māori octogenarians, in Te Puawaitanga O Nga Tapuwae Kia Ora Tonu – Life and Living in Advanced Age (LILACs) cohort study. Cell phone use was 16% in Māori octogenarians and 30% in non-Māori octogenarians; cell phone use was less likely in Māori supported only by a pension than Māori with more income. Internet use was associated with higher cognition scores and was 6% in Māori octogenarians and 19% in non-Māori octogenarians. Watching pay-per-view television (e.g. SKY) was less likely in women, octogenarians who lived alone, and non-Māori supported only by a pension. The authors commented that ‘Relatively low use of technology may limit potential for health technology innovation for people of advanced age.’
Although telephone consultations during lockdown (levels 3 and 4) may be liked by some, it won’t work for all without focused effort, as this article describes. In the same way the Ministry of Education and schools provided tablets and other support to tamariki so that they could access ‘virtual’ schooling, we should think about supporting our kaumatua to access technology so that they have equitable access to healthcare and other support services.
Independent commentary by Dr. Matire Hardwood
Dr Matire Harwood (Ngapuhi) has worked in Hauora Māori, primary health and rehabilitation settings as clinician and researcher since graduating from Auckland Medical School in 1994. She also holds positions on a number of boards, committees and advisory groups including the Health Research Council. Matire lives in Auckland with her whānau including partner Haunui and two young children Te Rangiura and Waimarie.
Research Review publications are intended for New Zealand health professionals.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.
